Frontiers in Pharmacology | Inflammation Pharmacology

Original Research

Published on 20 Dec 2024

The endocannabinoid anandamide prevents TH17 programming of activated T lymphocytes while preserving TH1 responses

in Inflammation Pharmacology

Anastasiia Kiprina
Tom Teichmann
Virna Margarita Martín Giménez
Wenqing Xu
Fiona Sailer
Maike Windbergs
Walter Manucha
Andreas Weigert
Ralf P. Brandes

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1528759

1,459 views

Original Research

Published on 19 Dec 2024

Microglial adenosine A2A receptor in the paraventricular thalamic nucleus regulates pain sensation and analgesic effects independent of opioid and cannabinoid receptors

in Inflammation Pharmacology

Yiping Cao
Zhou Wu
Moruo Zhang
Ran Ji
Hongxing Zhang
Lingzhen Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1467305

1,437 views
2 citations

Correction

Published on 16 Dec 2024

Corrigendum: Apolipoprotein A-I attenuates peritoneal fibrosis associated with peritoneal dialysis by inhibiting oxidative stress and inflammation

in Inflammation Pharmacology

Jing Lu
Jie Gao
Jing Sun
Haiping Wang
Huijuan Sun
Qian Huang
Yao Zhang
Shuo Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1532774

689 views

Review

Published on 12 Dec 2024

The advent of chimeric antigen receptor T Cell therapy in recalibrating immune balance for rheumatic autoimmune disease treatment

in Inflammation Pharmacology

Qianyu Guo
Jie Li
Juanjuan Wang
Linxin Li
Jia Wei
Liyun Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1502298

5,350 views
1 citation

Review

Published on 06 Dec 2024

Decoding ferroptosis: transforming orthopedic disease management

in Inflammation Pharmacology

Guanlin Huo
Yumeng Lin
Lusheng Liu
Yuqi He
Yi Qu
Yang Liu
Renhe Zhu
Bo Wang
Qing Gong
Zhongyu Han

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1509172

3,332 views
2 citations

Review

Published on 04 Dec 2024

New insights into SUMOylation and NEDDylation in fibrosis

in Inflammation Pharmacology

Jin Han
Jun Wu
Wen-Tao Kou
Li-Na Xie
Ya-Li Tang
Da-Long Zhi
Ping Li
Dan-Qian Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476699

2,172 views

Editorial

Published on 04 Dec 2024

Editorial: Recent advances in the pathogenesis and potential biomarkers of fibrosis

in Inflammation Pharmacology

Samar A. Antar
Aymen Halouani
Karim Tawfic
Walied Abdo
Ayman M. Mahmoud
Yassine Sassi

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1527123

664 views

Original Research

Published on 26 Nov 2024

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

in Inflammation Pharmacology

Alessandra Ammazzalorso
Stefania Tacconelli
Annalisa Contursi
Ulrika Hofling
Carmen Cerchia
Sara Di Berardino
Alessandra De Michele
Rosa Amoroso
Antonio Lavecchia
Paola Patrignani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1488722

1,786 views

Original Research

Published on 21 Nov 2024

Polyvinylalcohol-carbazate mitigates acute lung injury caused by hydrochloric acid

in Inflammation Pharmacology

Caijuan Dong
Jielu Liu
Alessandro Quaranta
Xu Jing
Mu Nie
Craig E. Wheelock
Benjamin Murrell
Jonathan M. Coquet
Tim Melander Bowden
Thomas Engstrand

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1503648

1,512 views
1 citation

Correction

Published on 08 Nov 2024

Corrigendum: Efficacy of hyaluronic acid in the treatment of nasal inflammatory diseases: a systematic review and meta-analysis

in Inflammation Pharmacology

Huixia Liu
Yue Chen
Huan Wang
Xinyi Luo
Dengpiao Xie
Qing Ji
Li Tian

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1404434

840 views
1 citation

Review

Published on 07 Nov 2024

Estrogen: the forgotten player in metaflammation

in Inflammation Pharmacology

Bao-Ting Zhu
Qing-Qing Liao
Hai-Ying Tian
Dao-Jiang Yu
Teng Xie
Xi-Lu Sun
Xin-Meng Zhou
Ying-Xuan Han
Yu-Jie Zhao
Mohamed El-Kassas

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1478819

3,431 views
4 citations

Review

Published on 06 Nov 2024

P4HA1: an important target for treating fibrosis related diseases and cancer

in Inflammation Pharmacology

Xuewen Yang
Dong Zhang
Mengmeng Li
Yingchun Shao
Xiyang Zhang
Yongzhi Xue

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1493420

3,063 views

Review

Published on 05 Nov 2024

The impact of diabetes mellitus on tendon pathology: a review

in Inflammation Pharmacology

Jian Xu
Jinbo Wang
Yuncong Ji
Yanlong Liu
Jishi Jiang
Yanbo Wang
Xilong Cui
Yunpeng Wan
Biao Guo
Haiyang Yu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1491633

2,695 views
2 citations

Editorial

Published on 31 Oct 2024

Editorial: Chronic pain: what is the mechanism?

in Inflammation Pharmacology

James David Adams
Ching-Liang Hsieh
Roberta Gualdani

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1496510

837 views

Case Report

Published on 30 Oct 2024

Mycophenolate mofetil after tacrolimus for refractory clinically amyopathic dermatomyositis: a case report

in Inflammation Pharmacology

Gui-Chen Ling
Chang Su
Ying-Ao Guo
Xia Qiu
Jia-Wei Liu
Min Xiao
Yu-Ya Xiao
Shuo Yang
Jian-Yong Zhang
Jing-Jing Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1472667

1,846 views

Review

Published on 29 Oct 2024

JAK inhibitors: an evidence-based choice of the most appropriate molecule

in Inflammation Pharmacology

Luca Antonioli
Alessandro Armuzzi
Massimo Claudio Fantini
Matteo Fornai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1494901

4,237 views
1 citation